ArticleBMC plant biology2026
Comprehensive metabolomics and transcriptomics analysis to explore variations in components of Alpinia oxyphylla from four distinct areas.
Article in BMC plant biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alpinia oxyphylla Miq, commonly known as Yi Zhi Zi in China, has been utilized for treating a range of illnesses. The differential metabolites and DEGs contributing to regional variations in medicinal values remain unidentified. This study explored metabolomic and transcriptomic differences among four A. oxyphylla plants from different locations. In total, 1874 metabolites were analyzed in the YZ1 vs. YZ2 comparison, 2492 in the YZ1 vs. YZ3 comparison, and 2452 in the YZ1 vs. YZ4 comparison. Additionally, 2143 metabolites were examined in the YZ2 vs. YZ3 comparison, 2180 in the YZ2 vs. YZ4 comparison, and 2637 in the YZ3 vs. YZ4 comparison. In the present study, prunetin was more abundant in Hainan-Danzhou than in Hainan-Qiongzhong and was highly accumulated in Hainan-Baisha compared with Hainan-Qiongzhong. Isorhamnetin 3-(6''-malonylglucoside) and Isorhamnetin were more abundant in Hainan-Wuzhishan than in Hainan-Baisha. Isorhamnetin was highly accumulated in Hainan-Wuzhishan compared with Hainan-Qiongzhong. Prunetin, Isorhamnetin 3-(6''-malonylglucoside) and Isorhamnetin belong to the category of flavonoid. Ophiobolin A was more abundant in the A. oxyphylla fruits from Hainan-Qiongzhong than Hainan-Danzhou and was highly accumulated in Hainan-Baisha compared with Hainan-Danzhou. Soyasapogenol B was highly accumulated in Hainan-Baisha compared with Hainan- Qiongzhong. Paeoniflorin was more abundant in the A. oxyphylla fruits from Hainan-Qiongzhong than Hainan-Wuzhishan. Nomilin was more abundant in the A. oxyphylla fruits from Hainan- Baisha than Hainan-Wuzhishan. The DEGs of chalcone synthase (CHS: Cluster-79122.1) was highly expressed in YZ3 and YZ4. The DEGs of chalcone isomerase (CHI: Cluster-28615.25) was highly expressed in YZ3. The DEGs of flavanone 3-hydroxylase (F3H: Cluster-78576.0 and Cluster-78576.1) were highly expressed in YZ2. The expression levels of TPS (Cluster-92493.1) were significantly increased in YZ2 and YZ4 samples compared to YZ1 and YZ3. We speculated that the flavonoids and terpenoids may play crucial roles in the different medicinal values in the A. oxyphylla fruits from four regions. These findings elucidate the metabolomic and transcriptomic characteristics of A. oxyphylla across various regions, offering a foundation for the pharmaceutical potential of new A. oxyphylla species.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.